KYMR
Price
$41.47
Change
+$4.25 (+11.42%)
Updated
Jan 14, 04:06 PM (EDT)
Capitalization
2.47B
37 days until earnings call
TRML
Price
$18.59
Change
-$0.89 (-4.57%)
Updated
Jan 14, 04:16 PM (EDT)
Capitalization
499.26M
Ad is loading...

KYMR vs TRML

Header iconKYMR vs TRML Comparison
Open Charts KYMR vs TRMLBanner chart's image
Kymera Therapeutics
Price$41.47
Change+$4.25 (+11.42%)
Volume$547
Capitalization2.47B
Tourmaline Bio
Price$18.59
Change-$0.89 (-4.57%)
Volume$201
Capitalization499.26M
KYMR vs TRML Comparison Chart
Loading...
KYMR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TRML
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
KYMR vs. TRML commentary
Jan 15, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is KYMR is a StrongBuy and TRML is a Hold.

Ad is loading...
COMPARISON
Comparison
Jan 15, 2025
Stock price -- (KYMR: $37.22 vs. TRML: $19.47)
Brand notoriety: KYMR and TRML are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: KYMR: 108% vs. TRML: 142%
Market capitalization -- KYMR: $2.47B vs. TRML: $499.26M
KYMR [@Biotechnology] is valued at $2.47B. TRML’s [@Biotechnology] market capitalization is $499.26M. The market cap for tickers in the [@Biotechnology] industry ranges from $385.53B to $0. The average market capitalization across the [@Biotechnology] industry is $2.41B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

KYMR’s FA Score shows that 0 FA rating(s) are green whileTRML’s FA Score has 1 green FA rating(s).

  • KYMR’s FA Score: 0 green, 5 red.
  • TRML’s FA Score: 1 green, 4 red.
According to our system of comparison, TRML is a better buy in the long-term than KYMR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

KYMR’s TA Score shows that 4 TA indicator(s) are bullish while TRML’s TA Score has 4 bullish TA indicator(s).

  • KYMR’s TA Score: 4 bullish, 3 bearish.
  • TRML’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, KYMR is a better buy in the short-term than TRML.

Price Growth

KYMR (@Biotechnology) experienced а -6.72% price change this week, while TRML (@Biotechnology) price change was -10.44% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -7.05%. For the same industry, the average monthly price growth was -1.49%, and the average quarterly price growth was -2.91%.

Reported Earning Dates

KYMR is expected to report earnings on May 01, 2025.

TRML is expected to report earnings on Mar 15, 2024.

Industries' Descriptions

@Biotechnology (-7.05% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
KYMR($2.47B) has a higher market cap than TRML($499M). TRML YTD gains are higher at: -3.994 vs. KYMR (-7.482). TRML has higher annual earnings (EBITDA): -78.78M vs. KYMR (-160.96M). KYMR has more cash in the bank: 550M vs. TRML (282M). TRML has less debt than KYMR: TRML (290K) vs KYMR (88.2M). KYMR has higher revenues than TRML: KYMR (87.6M) vs TRML (0).
KYMRTRMLKYMR / TRML
Capitalization2.47B499M495%
EBITDA-160.96M-78.78M204%
Gain YTD-7.482-3.994187%
P/E RatioN/AN/A-
Revenue87.6M0-
Total Cash550M282M195%
Total Debt88.2M290K30,414%
TECHNICAL ANALYSIS
Technical Analysis
KYMRTRML
RSI
ODDS (%)
N/A
Bullish Trend 7 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 7 days ago
84%
Bearish Trend 7 days ago
81%
Momentum
ODDS (%)
Bearish Trend 7 days ago
85%
Bearish Trend 7 days ago
89%
MACD
ODDS (%)
Bullish Trend 7 days ago
76%
Bullish Trend 7 days ago
86%
TrendWeek
ODDS (%)
Bullish Trend 7 days ago
81%
Bearish Trend 7 days ago
89%
TrendMonth
ODDS (%)
Bearish Trend 7 days ago
87%
Bearish Trend 7 days ago
88%
Advances
ODDS (%)
Bullish Trend 12 days ago
85%
Bullish Trend 9 days ago
85%
Declines
ODDS (%)
Bearish Trend 16 days ago
88%
Bearish Trend 7 days ago
87%
BollingerBands
ODDS (%)
Bullish Trend 7 days ago
76%
Bullish Trend 7 days ago
89%
Aroon
ODDS (%)
Bearish Trend 7 days ago
84%
Bearish Trend 7 days ago
88%
View a ticker or compare two or three
Ad is loading...
KYMR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TRML
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
NDVCX16.290.17
+1.05%
MFS New Discovery Value C
BIAYX10.05N/A
N/A
Brown Advisory Sustainable Sml-Cp Cr Inv
GSSUX39.18N/A
N/A
Goldman Sachs Small Cap Value R6
HSLIX43.43-0.02
-0.05%
Hartford Small Cap Growth I
RNWHX74.87-0.61
-0.81%
American Funds New World R5E

KYMR and

Correlation & Price change

A.I.dvisor indicates that over the last year, KYMR has been loosely correlated with CCCC. These tickers have moved in lockstep 60% of the time. This A.I.-generated data suggests there is some statistical probability that if KYMR jumps, then CCCC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KYMR
1D Price
Change %
KYMR100%
-2.49%
CCCC - KYMR
60%
Loosely correlated
-4.50%
ERAS - KYMR
49%
Loosely correlated
-9.09%
CRSP - KYMR
49%
Loosely correlated
-2.12%
ACLX - KYMR
48%
Loosely correlated
-2.49%
XENE - KYMR
47%
Loosely correlated
-0.42%
More

TRML and

Correlation & Price change

A.I.dvisor indicates that over the last year, TRML has been closely correlated with SPHDF. These tickers have moved in lockstep 78% of the time. This A.I.-generated data suggests there is a high statistical probability that if TRML jumps, then SPHDF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TRML
1D Price
Change %
TRML100%
-1.17%
SPHDF - TRML
78%
Closely correlated
N/A
IMNM - TRML
38%
Loosely correlated
-5.28%
SLRN - TRML
36%
Loosely correlated
+4.37%
KYMR - TRML
35%
Loosely correlated
-2.49%
VYGR - TRML
35%
Loosely correlated
-3.12%
More